CING · Cingulate Inc.
AI read · Good for CING
The AI's read
Completing the FDA-requested manufacturing work brings CTx-1301 closer to another review. The application has not yet been resubmitted, so that step remains ahead. The cash can support regulatory work and launch preparation, but the stated funding period is limited.